Accuitis
Atlanta, US · 2 known investors
Find your way into Accuitis
Sign up to find every way you can get introduced to Accuitis
- Your email: who you already know at Accuitis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Accuitis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
Investors · 2
Frequently asked questions
- What does Accuitis do?
- Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
- Who are Accuitis's investors?
- Accuitis's investors include Atlanta Technology Angels, GRA Venture.
- Where is Accuitis headquartered?
- Accuitis is headquartered in Atlanta, US.
